ISP-001

N/A

Report date: 2023/01/13 20:00:32

Base Information

Drug NameISP-001
Drug Alias NameSleeping Beauty Transposon-Engineered Autologous Plasmablasts for Expression and Delivery of Alpha-L-IduronidaseISP-001
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionAlpha-L-iduronidase gene transference
TargetsAlpha-L-iduronidase
Therapy Area/IndicationsMucopolysaccharidosis I
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmusoft Corp
China Registration ClassN/A

Develop Information

Active CompaniesImmusoft of CA Inc
Inactive CompaniesImmusoft Corp
Active IndicationsMucopolysaccharidosis I
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A